Coenzyme Q10

What Coenzyme Q10 actually measures — the analyte, and the assay

The analyte is coenzyme Q10, and it arrives in the tube in two redox states: ubiquinone (oxidized) and ubiquinol (reduced). In fresh human plasma the great majority is ubiquinol, and ubiquinol oxidizes on standing. So the number depends on how quickly the sample was separated, frozen and kept dark — a pre-analytical sensitivity most reports never mention.

The molecule is a benzoquinone head on a tail of 10 isoprenoid units — the 10 in the name, and the reason it is lipid-soluble and sits in membranes rather than in water. Humans synthesize it through the mevalonate pathway, the same route that makes cholesterol, with HMG-CoA reductase as the shared committed step and farnesyl pyrophosphate as the branch point. Its day job is inside the mitochondrial inner membrane, carrying electrons between complex I or II and complex III; a plasma concentration is several compartments away from that.

The redox state is enzymatically maintained: NAD(P)H:quinone oxidoreductase 1 reduces ubiquinone back to ubiquinol, which is why the ratio in a fresh sample reflects biology and the ratio in a slowly processed one reflects the courier.

Measurement is by HPLC with electrochemical or UV detection, or by LC-MS/MS. The honest state of the field is in the method-validation literature itself: a 2022 paper validating a new HPLC-ED method reports on the external quality control scheme for CoQ10 and notes that the scheme's global quality would be improved by more laboratories taking part Paredes-Fuentes 2022. Translated: there is no widely harmonized assay and no certified reference material in routine use, so CoQ10 numbers do not travel between laboratories the way a sodium does.

And then the fact that reframes the whole test. CoQ10 is a lipid. It does not float in plasma; it rides in lipoproteins, predominantly LDL. Plasma CoQ10 therefore co-varies with LDL-cholesterol almost by construction, and the quantity with any interpretive meaning is the ratio of CoQ10 to total or LDL cholesterol, not the raw concentration. Anything that lowers your LDL lowers your measured CoQ10 without a single mitochondrion being involved.

Coenzyme Q10: what changes the blood, and what only changes the reading

What changes the coenzyme in your body:

1. Primary genetic CoQ10 deficiency — rare, and diagnosed in tissue rather than plasma.
2. Secondary deficiency in mitochondrial respiratory chain disease, where the biochemical assessment is performed on muscle or cultured fibroblasts, not serum Turton 2022.
3. Supplementation, which is dose- and formulation-dependent and poorly absorbed without dietary fat.
4. Age, and advanced heart failure.

What changes only the reading:

1. Your LDL-cholesterol. This is the largest non-biological term and it is the one nobody adjusts for. A person whose LDL falls by a third will see their plasma CoQ10 fall without any change in tissue CoQ10.
2. Statins — and here the honest answer cuts against this page's own premise. Statins inhibit HMG-CoA reductase, which sits upstream of both cholesterol and the isoprenoid tail of CoQ10, so a depletion effect is mechanistically expected. But when it was measured directly — retinol, α-tocopherol and coenzyme Q10 in children with familial hypercholesterolemia on statin therapy — the analysis found no significant difference in any of the three against comparison groups, and concluded there was no rationale for routine antioxidant supplementation in that population Motkowski 2022. One study in one population is not the last word, but a page that cites the mechanism and hides the negative measurement is selling something.
3. Redox state and sample handling — delay to freezing, light exposure, freeze–thaw Paredes-Fuentes 2022.
4. Time since the last capsule, and the fat content of the meal it was taken with.

The absorption problem is not a detail. CoQ10 is an 863 Da lipid with poor and strongly formulation-dependent bioavailability, so two products at the same labeled dose can produce different plasma concentrations, and a capsule taken without dietary fat can produce almost none. A plasma CoQ10 is as much a measurement of the product and the meal as of the person.

Numbers for orientation. Plasma CoQ10 sits near 1 µmol/L in health and over 90% of it is ubiquinol. A 100 mg dose taken with a fatty meal can produce several times the plasma rise of the same dose taken fasted. Supplementation plateaus in 2–4 weeks. None of those numbers describes the mitochondrial pool the argument is about.

Reference interval or decision threshold — which kind of number Coenzyme Q10 is

A reference interval, and a soft one. No guideline body publishes an outcome-anchored plasma CoQ10 target for adults; nobody has shown a concentration above which anything improves. The site's own verdict for this marker is none, and that is the correct answer.

The numbers that behave more like thresholds live in metabolic medicine and are applied to muscle or fibroblast CoQ10 in suspected primary deficiency, where they are laboratory-specific and interpreted beside respiratory chain enzyme activities Turton 2022. Where plasma CoQ10 is being evaluated as a diagnostic biomarker in its own right — for instance in distinguishing parkinsonian syndromes — it is still at the stage of being evaluated, not of having a cut-off Bartošová 2023.

The practical consequence: a plasma CoQ10 near the bottom of the printed range in someone with a low LDL is usually arithmetic, and should be read as a ratio before it is read as a deficiency.

How you would know your Coenzyme Q10 was wrong — and when to redraw

Twelve weeks, and the reason is the intervention rather than the molecule. Plasma CoQ10 responds to an oral dose within days and reaches a plateau in roughly two to four weeks; it falls back over a similar period after stopping, because there is no large circulating reserve. If you only wanted to know whether the capsule is absorbed, four weeks answers it. Twelve is chosen because the symptom you are trying to change — myalgia, fatigue, exercise tolerance — takes that long to judge.

Conditions that must match: same laboratory, fasted, and the same interval since the last dose, written on the form. And the non-negotiable one — draw a lipid panel on the same sample, because a CoQ10 without a cholesterol beside it cannot be interpreted.

What would have to change for a second value to mean anything. A rise in CoQ10 that is not matched by a rise in ApoB and LDL-cholesterol — that is the part attributable to the supplement rather than to the carrier. Plus a change in the symptom that prompted the test. If the question is statin-associated muscle symptoms, creatine kinase belongs on the same draw, and the interpretation has to survive the negative finding above: measured directly, statin therapy did not significantly lower plasma CoQ10 in the population where it was looked for Motkowski 2022.

What Coenzyme Q10 cannot tell you

Plasma CoQ10 cannot tell you the CoQ10 content of muscle, heart or brain — the tissues the argument is about. Tissue assessment is done on muscle or fibroblasts Turton 2022.

It cannot diagnose a mitochondrial disease. That is a respiratory-chain, genetic and histological diagnosis.

It cannot establish that a muscle symptom is statin-related. Statin myalgia has no confirmatory blood test, and the largest randomized evidence in this space is about whether supplementation relieves the symptom, not about whether the concentration explains it.

A normal value does not exclude a tissue deficiency, and a low one in a person with low cholesterol is usually the lipoprotein, not the mitochondrion. The wrong inference this marker invites is precise: someone starts a statin, their LDL halves, their CoQ10 falls with it, and the fall is read as proof the statin is causing their aching legs. It is the same molecule doing two jobs on one report — and the one study that measured retinol, tocopherol and CoQ10 under statin therapy found no significant depletion of any of them Motkowski 2022.

Sources read for these sections

• Paredes-Fuentes AJ, et al. Technical Aspects of Coenzyme Q10 Analysis: Validation of a New HPLC-ED Method. Antioxidants 2022 · PMID 35326178
• Turton N, et al. The Biochemical Assessment of Mitochondrial Respiratory Chain Disorders. International Journal of Molecular Sciences 2022 · PMID 35806492
• Bartošová T, et al. Coenzyme Q10: A Biomarker in the Differential Diagnosis of Parkinsonian Syndromes. Antioxidants 2023 · PMID 38136223
• Motkowski R, et al. Effect of Statin Therapy on the Plasma Concentrations of Retinol, Alpha-Tocopherol and Coenzyme Q10 in Children with Familial Hypercholesterolemia. Cardiovascular Drugs and Therapy 2022 · PMID 33052507